The pontiff underwent surgery to remove part of his right lung after doctors discovered a cancerous nodule, raising questions about the disease, its treatment and long-term outlook.

October 14, 2026

The Vatican's announcement that Pope Leo XIV has been diagnosed with pulmonary adenocarcinoma, a common form of lung cancer, has brought renewed attention to the importance of early detection and advances in cancer treatment.

According to the Vatican's statement on October 13, the pontiff underwent surgery to remove a portion of his right lung after physicians identified a cancerous nodule.

The development has raised concerns about the pope's health early in his papacy, while also highlighting a disease that affects thousands of people worldwide.

Although lung cancer remains one of the leading causes of cancer-related deaths, medical specialists emphasize that patients diagnosed in the earliest stages often have significantly better treatment outcomes.

What Is Pulmonary Adenocarcinoma?

Pulmonary adenocarcinoma is the most common subtype of lung cancer. It develops in glandular cells within the lungs and belongs to a broader category known as non-small cell lung cancer.

Although smoking is a major risk factor, the disease can also develop in people who have never smoked.

Other potential risk factors include prolonged exposure to secondhand smoke, radon gas, asbestos and certain environmental pollutants.

One of the challenges associated with pulmonary adenocarcinoma is that it can progress without producing noticeable symptoms, particularly during its early stages.

When symptoms do appear, they may include persistent coughing, shortness of breath, chest discomfort, coughing up blood and changes in respiratory function.

Because these warning signs can resemble those of other respiratory conditions, medical evaluation is important when symptoms persist.

How Is This Type of Lung Cancer Treated?

Treatment depends largely on the cancer's stage, the size and location of the tumor, and the patient's overall health.

When pulmonary adenocarcinoma is detected before it has spread, surgery can offer an effective treatment option.

Doctors may remove a small section of lung tissue, an entire lobe or, in certain circumstances, a larger portion of the affected lung.

In Pope Leo XIV's case, Vatican officials reported that surgeons removed part of his right lung.

According to Dr. Raja Flores, chairman of thoracic surgery at Mount Sinai Health System in New York, patients whose cancer is discovered early can experience favorable long-term outcomes following surgery.

He also explained that many individuals can return to normal activities, including exercise, after recovering from lung surgery.

Additional treatments may be recommended depending on the patient's condition and the cancer's characteristics.

Chemotherapy, immunotherapy and other targeted approaches can be used before or after surgery to reduce the risk of remaining cancer cells or disease recurrence.

For patients with more advanced cancer, treatment plans may involve combinations of medication, radiation therapy and other specialized interventions.

Can Patients Recover After Lung Surgery?

Recovery following lung surgery varies from person to person, but many patients are able to resume active and independent lives.

The amount of lung tissue removed, the patient's existing respiratory health and any additional medical conditions can influence recovery.

Specialists generally encourage appropriate physical rehabilitation and continued medical supervision.

Even after successful surgery, patients require follow-up appointments because lung cancer can return.

Doctors commonly recommend periodic CT scans, sometimes every six months during the initial surveillance period, to identify potential recurrence.

The likelihood of cancer returning depends on factors such as tumor size, stage at diagnosis and biological characteristics.

The Vatican has not provided enough publicly detailed medical information in the supplied report to determine the pope's precise prognosis.

What Are the Survival Rates for Lung Cancer?

Lung cancer continues to represent a major public health challenge in the United States.

According to figures cited from the Centers for Disease Control and Prevention, approximately 128,000 Americans died from lung cancer in 2024.

The overall five-year relative survival rate for lung cancer is approximately 30%.

However, survival rates improve substantially when the disease is detected before it spreads beyond the lungs.

For patients diagnosed with localized lung cancer, the five-year relative survival rate is approximately 60%.

Medical experts caution that these statistics represent broad population averages and cannot predict the outcome for an individual patient.

Dr. Edward Chan, chief of thoracic surgery at MedStar Washington Hospital Center, emphasized that historical survival figures may not fully reflect advances in modern treatment or a patient's individual circumstances.

Why Early Detection Matters

One of the most important factors in improving lung cancer outcomes is identifying the disease before symptoms develop or the cancer spreads.

Low-dose computed tomography, commonly called a low-dose CT scan, is an important screening tool for individuals at elevated risk.

The U.S. Preventive Services Task Force recommends annual lung cancer screening for adults between 50 and 80 years old who have at least a 20-pack-year smoking history and currently smoke or quit within the past 15 years.

The American Cancer Society also recommends annual screening for eligible adults in the same age range with a substantial smoking history, without imposing the same 15-year limit after quitting.

Individuals with a family history of lung cancer or concerning respiratory symptoms should discuss their personal risk factors with a healthcare professional.

Medical specialists also emphasize that avoiding tobacco, quitting smoking and reducing exposure to harmful substances can help lower the likelihood of developing lung cancer.

Pope Leo XIV's Diagnosis Highlights Advances in Cancer Care

The announcement concerning Pope Leo XIV has drawn international attention to pulmonary adenocarcinoma and the importance of timely medical intervention.

While questions remain about the pontiff's recovery and future health, the reported surgical treatment illustrates one of the principal approaches used when lung tumors can be removed.

Doctors emphasize that a cancer diagnosis does not automatically mean a poor prognosis, particularly when the disease is discovered early and appropriate treatment is available.

Advances in surgical techniques, diagnostic imaging, immunotherapy and targeted medications continue to improve treatment options for many patients.

The Bottom Line

Pulmonary adenocarcinoma is a serious but potentially treatable form of lung cancer, especially when identified at an early stage.

Pope Leo XIV's reported diagnosis underscores the value of medical screening, prompt evaluation of suspicious lung abnormalities and access to specialized treatment.

Although the pontiff's individual prognosis remains uncertain, medical experts agree that early diagnosis and careful follow-up can make a substantial difference in long-term outcomes.

Medical note: This article is intended for general informational purposes and is not a substitute for professional medical advice. The details concerning Pope Leo XIV are based on the supplied October 13, 2026 report.